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Abstract
Introduction: Prostate cancer has a high tendency to spread to bone. Pulmonary metastasis and
generalized lymphadenopathy commonly develop after pelvic and bone involvement have already
occurred. Few patients with prostate cancer present initially with symptomatic metastatic lung
lesions and lymphadenopathy without any other concomitant distant dissemination.
Case presentation: We report a case of a 73-year-old white male who sought medical help for
symptoms of cough, hemoptysis, and dyspnea. A chest X-ray was done revealing multiple "cannon
ball" infiltrates involving all segments of the lung parenchyma. Fine-needle aspiration cytology under
computed tomography guidance of a subpleural lesion revealed adenocarcinomatous cells. Despite
the absence of any detectable osseous lesions and with the presence of multiple hilar, mediastinal,
para-aortic, and pelvic lymphadenopathy, the patient had a complete work-up in search for the
primary adenocarcinoma. His prostate specific antigen was 146 ng/ml and a prostatic biopsy done,
revealing an acinar prostatic adenocarcinoma. A tru-cut biopsy of a lung lesion under computed
tomography guidance showed a metastatic prostatic adenocarcinoma positive for prostate specific
antigen stain.
Conclusion: This case sheds light on an unusual metastatic pattern of prostatic adenocarcinoma.
It also emphasizes the importance of including prostate cancer in the differential diagnosis of men
with adenocarcinoma of unknown origin.
Introduction
Few reports in the literature have described an unusual
pattern of presentation of metastatic prostate cancer. Pul-
monary metastases are not encountered commonly in
patients with prostate cancer. We report a case of a patient
with prostatic carcinoma, whose pulmonary manifesta-
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tions were the only evidence of his disseminated disease
[1-3].
The patient had pulmonary metastatic lesions, rather than
the conventional pattern of osseous metastases with sub-
sequent pulmonary involvement commonly seen in
patients with prostate adenocarcinoma. His pulmonary
symptoms were not associated with other symptoms per-
tinent to a primary prostate neoplasia including lower uri-
nary tract symptoms. Androgen deprivation remains an
effective treatment and, among hormone-naïve patients,
objective response is common [2].
Case presentation
A 73-year-old white man with no relevant past medical or
surgical histories, presented with symptoms of cough,
progressive dyspnea, and two episodes of hemoptysis, not
associated with any fever, weight loss, or night sweats. The
patient did not report any symptom suggestive of urinary
obstruction such as hesitancy, intermittency, weak stream,
dribbling, or incomplete void. He was referred by his fam-
ily physician to a pulmonologist, who in turn asked for a
complete work-up including a chest X-ray, complete
blood count, and a serum biochemical evaluation. The
patient's laboratory evaluation was within normal ranges
with a creatinine of 1 mg/dl (N<1.3 mg/dl), alkaline
phosphatase of 75 U/L (N<104 U/L), and no evidence of
anemia, leukocytosis, hypoalbuminemia, electrolyte
imbalance or disturbed liver function tests. His X-ray film
showed "extensive cannon-ball type lesions" involving
both lungs.
The patient underwent an enhanced computed tomogra-
phy (CT)-scan of the chest, abdomen, and pelvis. The CT-
scan of chest showed a diffuse nodular type of metastatic
disease involving all segments, with multiple pleural
based lesions ranging in size from few millimeters to 2 cm
(Figure 1). There was also evidence of multiple mediasti-
nal enlarged lymph nodes, the largest measuring 5.3 × 3.2
cm at the level of the left upper lobe bronchus. Few lymph
nodes were also noted in both axillae. No gross bony
lesions were observed. CT scan of the abdomen and pelvis
revealed multiple retrocrural, para-aortic, and pelvic
lymph nodes with no lesions seen in the liver, spleen,
pancreas, and adrenals. The patient had no ascites but had
an enlarged prostate with a volume equivalent to about 77
g.
The presence of the above described lesions of the lung
and enlarged lymph nodes raised the possibility of either
a primary lung cancer with diffuse metastases or a lym-
phoma.
Fine needle aspiration cytology of a subpleural lesion
under CT-guidance was suggestive of a non-small cell car-
cinoma that could probably be arising from an adenocar-
cinoma. The patient was asked to perform a series of tests
including an assessment of his prostate specific antigen
(PSA) which in turn was 146 ng/ml (N<4 ng/ml). His
high PSA was associated with the presence of a nodular
left prostatic lobe on digital rectal examination. A pros-
tatic biopsy revealed a moderately differentiated acinar
prostatic adenocarcinoma with a Gleason's score of 9
(4+5)/10. A whole-body bone scan revealed no evidence
of bone metastases.
A tru-cut biopsy of the lung under CT-guidance showed a
metastatic prostatic adenocarcinoma, identical to the pro-
static biopsy and positive on immunohistochemistry for
PSA and negative for cytokeratin 7 (Figure 2).
The patient was commenced on total androgen blockade
consisting of lutenizing hormone releasing hormone ana-
logue and nilutamide (anti-androgen). Three months
after therapy, PSA dropped to 0.19 ng/ml (N<4 ng/ml)
and a restaging chest CT-scan was done revealing a
remarkable decrease in the diffuse metastatic nodular
lung disease as well as in the mediastinal lymph nodes
(Figure 3).
Discussion
Prostate cancer accounts for about 25% of new cancers in
men [1]. The lungs are second or third only to bone and/
CT-scan taken at the level of the carina Figure 1
CT-scan taken at the level of the carina. Multiple meta-
static nodules evolving all the lung segments with bilateral 
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or lymph nodes as metastatic sites from prostate cancer
[4,5]. The reported incidence of clinically apparent pul-
monary metastases at initial diagnosis is 5–27% [2],
whereas autopsy rates show an incidence of between 23
and 74% [4,5]. Pulmonary lesions were part of the initial
pattern of metastases in 2% of the population and devel-
oped subsequent to other metastatic sites in 1.6% of the
population [2].
In this report, we document a case of prostate cancer
where pulmonary metastases and lymphadenopathy
occurred at presentation without any concomitant
osseous or multiorgan involvement [3]. Radiological pro-
files of pulmonary metastases in advanced prostate cancer
are commonly either lymphangitic or nodular, with the
former being more frequent since it is apparently a result
of direct invasion of lung lymphatics, while the nodular
pattern being the consequence of hematogenous spread
[2,4]. This patient had a nodular pattern on CT which is
usually associated with other forms of hematogenous
spread including bone involvement which was not evi-
dent in our case [6,7]. As a result, our patient seems to
have developed metastatic nodular disease because of
hematogenous spread, without developing bone metas-
tases. This pattern of spread opens the door for more
research venues about the pathophysiology of the mecha-
nisms underlying distant metastases in prostate adenocar-
cinoma.
Classically, two lymph node metastatic patterns were sug-
gested in prostate cancer: Pattern 1 includes metastases to
pelvic and para-aortic lymph nodes, while pattern 2
includes metastases to para-aortic nodes only. In Type 1
cases the lymph node metastases appeared to be continu-
ously invasive and significantly associated with less fre-
quent metastases to the lungs. The Type 2 lymph node
metastases may be a "skip-type metastases" or lymph
node metastases associated with hematogenous metas-
tases [5]. Our patient has most probably developed a
hematogenous spread of his prostatic cancer cells to both
lymph nodes and lung parenchyma [5]. Another major
feature which makes this patient unique in presentation
and difficult to diagnose is the presence of distant metas-
tases and lymphadenopathy in the absence of bone
involvement. The above mentioned clinical findings are
relatively uncommon upon initial diagnosis [8] and the
absence of urinary symptoms might mask the suspicion of
prostate cancer as the primary adenocarcinoma that mim-
ics a metastatic lung cancer or a lymphoma [9]. The rapid
and dramatic regression of the lung lesions and of the
lymph nodes confirms their metastatic nature and shows
androgen deprivation to be an effective mode of pallia-
A- Lung mass biopsy showing moderately differentiated adenocarcinoma, medium power Figure 2
A- Lung mass biopsy showing moderately differentiated adenocarcinoma, medium power. B- Inset: PSA immuno-
histochemical stain of tumor cells are strongly positive.
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tion even for metastatic prostate cancer without bone
involvement.
Conclusion
This report emphasizes the importance of suspecting pros-
tate cancer in men presenting with secondary lesions in
the lung even in the absence of bone metastases. More
clinical and basic research is needed to understand the
molecular profile, epidemiology, and treatment options
and responses of patients with prostate adenocarcinoma
that present with lung metastases in the absence of bone
involvement. In this patient, hormonal therapy for pros-
tate cancer was also shown to be effective as first line treat-
ment [2,5,8].
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CT-scan taken at the level of the carina Figure 3
CT-scan taken at the level of the carina. Remarkable 
decrease in size and number of the nodular metastases as 
well as of the hilar lymph nodes.